In the world of medication adherence, the challenges are significant. Patients often struggle to consistently take the medications prescribed to them, and two key factors play a major role in this issue: accessibility and cost. Pharmacy Benefit Managers (PBMs) have been under scrutiny, as policymakers and regulatory agencies investigate their impact on drug pricing. The entire drug supply chain, with PBMs at the forefront, has created a system that inflates medication costs, making it difficult for patients to afford their prescriptions.
Amidst calls for reform, innovators in the prescription drug pricing transparency space are working to bring about change. One such innovator is GoodRx, spearheaded by Doug Hirsch, the Chief Mission Officer. GoodRx aims to foster a more transparent healthcare marketplace and believes that small solutions will not be enough to fix the endemic issues. The high cost of medications forces many patients to make tough choices between filling their prescriptions or paying for essential needs like housing or food. This has long-term consequences for healthcare quality and costs.
